CANCER OF ENDOMETRIUM
Clinical trials for CANCER OF ENDOMETRIUM explained in plain language.
Never miss a new study
Get alerted when new CANCER OF ENDOMETRIUM trials appear
Sign up with your email to follow new studies for CANCER OF ENDOMETRIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets aggressive uterine cancer
Disease control Recruiting nowThis study tests a personalized vaccine plus two approved drugs and an immune booster in people with advanced HER2-positive endometrial cancer. The vaccine is made from each participant's own blood cells and aims to help the immune system attack cancer. The goal is to see if this…
Matched conditions: CANCER OF ENDOMETRIUM
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Magic mushroom therapy targets Cancer-Related anxiety in new trial
Symptom relief Recruiting nowThis study tests whether a drug called NPX-5 (psilocybin) combined with talk therapy can reduce severe anxiety in people who have been diagnosed with cancer. About 87 adults aged 18 to 80 will receive one of three doses (25 mg, 10 mg, or 1 mg) during an 8-hour therapy session. Th…
Matched conditions: CANCER OF ENDOMETRIUM
Phase: PHASE2 • Sponsor: Psyence Australia Pty Ltd • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC